Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 116
interventional 99
Observational 16
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 43
Drug|Other 8
Biological|Drug 7
Device 5
Biological 4
Procedure 4
Other 3
Behavioral 2
Biological|Drug|Other 2
Biological|Drug|Procedure 2
Biological|Drug|Procedure|Radiation 2
Drug|Other|placebo 2
Drug|placebo 2
Behavioral|Dietary Supplement 1
Behavioral|Other 1
Biological|Other 1
Biological|Other|Procedure 1
Biological|placebo 1
Device|Drug 1
Diagnostic Test 1
Dietary Supplement 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|Radiation 1
Drug|Procedure|Radiation 1
Genetic|Other|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 64
China 4
United States|Canada 4
United Kingdom 3
Canada 2
France 2
NA 2
Belgium 1
Belgium|Croatia|Egypt|France|Netherlands 1
Belgium|Denmark|France|Netherlands|United Kingdom 1
Brazil 1
Brazil|Canada|Cyprus|United Kingdom 1
Cuba 1
Denmark 1
France|Ireland|United Kingdom 1
Germany 1
Italy 1
Japan 1
Netherlands 1
New Zealand 1
Sweden 1
Switzerland 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Canada|France 1
United States|France|Germany|Italy 1

Sites per Study

Site_count Study_Count
1 60
2 10
3 7
4 2
5 3
6 3
12 1
16 2
21 1
22 1
23 3
45 1
61 1
86 1
115 1
366 1
434 1

Phase

Phase Study_Count
Phase 1 42
Phase 2 25
N/A 16
Phase 1/Phase 2 7
Phase 3 7
Phase 2/Phase 3 1
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 29
2 19
3 5
4 1
6 1
NA 44

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 5.0000 3.00000 22 25.00 120 87.0000 116
1st Qu. 41.0000 18.50000 29 39.25 120 108.0000 116
Median 60.0000 34.00000 91 55.50 120 238.0000 116
Mean 294.5625 35.96296 155 83.20 120 284.6667 116
3rd Qu. 104.5000 42.00000 106 92.50 120 382.2500 116
Max. 3221.0000 108.00000 527 252.00 120 650.0000 116

Trial Group Type

group_type Group_Count
Experimental 71
NA 44
Active Comparator 13
No Intervention 4
Placebo Comparator 4

Intervention Model

intervention_model Study_Count
Single Group Assignment 37
NA 37
Parallel Assignment 22
Crossover Assignment 1
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 78
Supportive Care 14
Diagnostic 5
Other 1
Prevention 1

Observational Studies

Studies by Country

Country Study_Count
United States 9
France 2
China 1
Germany|Serbia|United Kingdom 1
Portugal|Spain 1
Sweden 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 7
2 2
3 1
5 1
10 1
12 1
17 1
19 1
32 1

Enrollment Metrics

Measure Observational
Min 17.0000
1st Qu 87.0000
Median 150.0000
Mean 515.6875
3rd Qu 263.2500
Max 5000.0000

Observation Model

observational_model Study_Count
Cohort 11
Case-Only 3
Case-Control 1
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 11
Cross-Sectional 4
Retrospective 1

Registries

Studies by Country

Country Study_Count
United States 1

Sites per Study

Site_count Study_Count
75 1

Enrollment Metrics

Measure Registries
Min 999999
1st Qu 999999
Median 999999
Mean 999999
3rd Qu 999999
Max 999999

Registry Model

observational_model Study_Count
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 1

Follow-up

target_duration Study_Count
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03375320 Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT03375320 Recruiting National Cancer Institute (NCI) 2021-01-01
NCT03350490 Bioinformation Therapy for Intestinal Cancer https://ClinicalTrials.gov/show/NCT03350490 Completed Fuda Cancer Hospital, Guangzhou 2018-11-30
NCT03280407 NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer https://ClinicalTrials.gov/show/NCT03280407 Recruiting Zealand University Hospital 2018-12-31
NCT03271255 Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) https://ClinicalTrials.gov/show/NCT03271255 Recruiting Shenzhen People’s Hospital 2022-09-30
NCT03072472 BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities https://ClinicalTrials.gov/show/NCT03072472 Completed South Tyneside and Sunderland NHS Foundation Trust 2018-02-13
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT02785783 Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection https://ClinicalTrials.gov/show/NCT02785783 Completed Portsmouth Hospitals NHS Trust 2018-08-07
NCT02585362 Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program https://ClinicalTrials.gov/show/NCT02585362 Completed Kantonsspital Winterthur KSW 2018-10-31
NCT02038114 The Impact of a Patient Education Intervention for Ambulatory Oncology Patients https://ClinicalTrials.gov/show/NCT02038114 Completed Sunnybrook Health Sciences Centre 2014-06-30
NCT03043664 Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT03043664 Active, not recruiting Duke University 2020-09-30
NCT02489422 Programs To Support You During Chemotherapy https://ClinicalTrials.gov/show/NCT02489422 Completed Wake Forest University Health Sciences 2020-01-31
NCT02381561 Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT02381561 Active, not recruiting National Cancer Institute (NCI) 2018-11-08
NCT02200055 Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need https://ClinicalTrials.gov/show/NCT02200055 Completed United States Naval Medical Center, Portsmouth 2015-07-31
NCT02185443 Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases https://ClinicalTrials.gov/show/NCT02185443 Recruiting University of Sao Paulo 2021-05-31
NCT01273090 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT01273090 Completed Children’s Oncology Group 2013-09-30
NCT01996306 A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC https://ClinicalTrials.gov/show/NCT01996306 Completed Epidemiological and Clinical Research Information Network 2017-11-20
NCT01995084 In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study https://ClinicalTrials.gov/show/NCT01995084 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2014-06-30
NCT01887158 Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection https://ClinicalTrials.gov/show/NCT01887158 Completed Ospedale Santa Maria delle Croci 2014-06-30
NCT01841736 Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors https://ClinicalTrials.gov/show/NCT01841736 Active, not recruiting National Cancer Institute (NCI) 2019-03-05
NCT01747096 TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT01747096 Completed Nantes University Hospital 2016-05-31
NCT04267575 Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites https://ClinicalTrials.gov/show/NCT04267575 Recruiting Jerome Canady Research Institute for Advanced Biological & Technological Sciences 2020-07-30
NCT04080843 Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients https://ClinicalTrials.gov/show/NCT04080843 Recruiting Zhejiang University 2020-08-31
NCT04077372 Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers https://ClinicalTrials.gov/show/NCT04077372 Recruiting Stanford University 2020-09-30
NCT03915171 Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer https://ClinicalTrials.gov/show/NCT03915171 Recruiting China Medical University, China 2019-12-01
NCT03891784 Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT03891784 Recruiting University of Washington 2023-09-30
NCT03608540 Endomina as an Aid for Endoscopic Full Thickness Resection https://ClinicalTrials.gov/show/NCT03608540 Recruiting Erasme University Hospital 2021-07-31
NCT03576872 The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients https://ClinicalTrials.gov/show/NCT03576872 Completed Dana-Farber Cancer Institute 2019-09-30
NCT03559543 Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03559543 Recruiting Catalysis SL 2020-11-30
NCT01263353 Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs https://ClinicalTrials.gov/show/NCT01263353 Completed Novartis 2014-03-31
NCT01204476 Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma https://ClinicalTrials.gov/show/NCT01204476 Completed National Cancer Institute (NCI) 2014-07-31
NCT01046864 Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) https://ClinicalTrials.gov/show/NCT01046864 Completed Bristol-Myers Squibb 2014-06-30
NCT01037049 Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks https://ClinicalTrials.gov/show/NCT01037049 Active, not recruiting Royal Marsden NHS Foundation Trust 2014-12-08
NCT01016639 Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer https://ClinicalTrials.gov/show/NCT01016639 Completed Lund University Hospital 2007-07-31
NCT01010126 Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer https://ClinicalTrials.gov/show/NCT01010126 Completed National Cancer Institute (NCI) 2017-03-13
NCT00994903 Simvastatin in Colorectal Surgery https://ClinicalTrials.gov/show/NCT00994903 Completed University of Auckland, New Zealand 2013-09-30
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer https://ClinicalTrials.gov/show/NCT00987766 Completed Vanderbilt-Ingram Cancer Center 2013-07-31
NCT01563991 Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes https://ClinicalTrials.gov/show/NCT01563991 Completed The Cleveland Clinic 2012-04-18
NCT01910974 Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System https://ClinicalTrials.gov/show/NCT01910974 Completed Hôpital Edouard Herriot 2014-02-28
NCT00734890 Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00734890 Completed National Institutes of Health Clinical Center (CC) 2010-06-30
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00646139 KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment https://ClinicalTrials.gov/show/NCT00646139 Completed Roswell Park Cancer Institute 2008-08-31
NCT00589563 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer https://ClinicalTrials.gov/show/NCT00589563 Completed City of Hope Medical Center 2012-02-29
NCT00569309 Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma https://ClinicalTrials.gov/show/NCT00569309 Completed Ohio State University Comprehensive Cancer Center 2011-07-29
NCT00562380 AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00562380 Completed National Cancer Institute (NCI) 2010-04-30
NCT00561418 Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma https://ClinicalTrials.gov/show/NCT00561418 Completed Ohio State University Comprehensive Cancer Center 2012-11-30
NCT00544193 Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00544193 Completed City of Hope Medical Center 2012-08-31
NCT00474994 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas https://ClinicalTrials.gov/show/NCT00474994 Completed Memorial Sloan Kettering Cancer Center 2010-11-30
NCT00454363 Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer https://ClinicalTrials.gov/show/NCT00454363 Completed National Cancer Institute (NCI) 2014-03-31
NCT00445965 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer https://ClinicalTrials.gov/show/NCT00445965 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT00433550 Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer https://ClinicalTrials.gov/show/NCT00433550 Completed Alliance for Clinical Trials in Oncology 2014-12-31
NCT00416351 Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin’s Lymphoma That Has Relapsed or Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00416351 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-07-31
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00088868 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma https://ClinicalTrials.gov/show/NCT00088868 Completed National Institutes of Health Clinical Center (CC) 2010-03-31
NCT00004258 EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004258 Completed Indiana University 2001-08-31
NCT00003939 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00003939 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-11-30
NCT00006039 Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00006039 Completed Memorial Sloan Kettering Cancer Center 2001-03-31
NCT00005021 Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma https://ClinicalTrials.gov/show/NCT00005021 Completed Fox Chase Cancer Center 2003-05-31
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00006357 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00006357 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-04-30
NCT00019344 Flavopiridol in Treating Patients With Refractory Cancer https://ClinicalTrials.gov/show/NCT00019344 Completed National Cancer Institute (NCI) NA
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT00019474 Completed Montefiore Medical Center 2000-08-31
NCT00005874 Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas https://ClinicalTrials.gov/show/NCT00005874 Completed National Cancer Institute (NCI) NA
NCT00004002 PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00004002 Completed NYU Langone Health 2001-10-31
NCT00002759 Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00002759 Completed National Cancer Institute (NCI) 2002-04-30
NCT00006348 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment https://ClinicalTrials.gov/show/NCT00006348 Completed Alliance for Clinical Trials in Oncology 2001-09-30
NCT00003368 Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis https://ClinicalTrials.gov/show/NCT00003368 Completed National Cancer Institute (NCI) NA
NCT00079261 Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00079261 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-03-31
NCT00004904 Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00004904 Completed Northwestern University 2000-07-31
NCT00003600 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00003600 Completed Alliance for Clinical Trials in Oncology 2001-12-31
NCT00016172 ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00016172 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00005634 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy https://ClinicalTrials.gov/show/NCT00005634 Completed Memorial Sloan Kettering Cancer Center 2002-10-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00006009 Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma https://ClinicalTrials.gov/show/NCT00006009 Completed National Cancer Institute (NCI) NA
NCT00005804 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00005804 Completed Fred Hutchinson Cancer Research Center 2002-08-31
NCT00042900 Pyroxamide in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00042900 Completed Memorial Sloan Kettering Cancer Center 2002-09-30
NCT00004911 Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction https://ClinicalTrials.gov/show/NCT00004911 Completed Northwestern University 2003-02-28
NCT00004910 Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction https://ClinicalTrials.gov/show/NCT00004910 Completed Northwestern University 2003-02-28
NCT00004895 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00004895 Completed Northwestern University 2002-10-31
NCT00049712 Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00049712 Completed University of Wisconsin, Madison 2006-02-28
NCT00049699 VNP40101M in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00049699 Completed National Cancer Institute (NCI) NA
NCT00049400 S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00049400 Completed Southwest Oncology Group 2006-09-30
NCT00036790 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00036790 Completed University of Wisconsin, Madison 2005-10-31
NCT00031941 CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy https://ClinicalTrials.gov/show/NCT00031941 Completed National Institutes of Health Clinical Center (CC) 2007-09-30
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00025441 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors https://ClinicalTrials.gov/show/NCT00025441 Completed National Cancer Institute (NCI) NA
NCT00025129 VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00025129 Completed National Cancer Institute (NCI) NA
NCT00019773 Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer https://ClinicalTrials.gov/show/NCT00019773 Completed National Cancer Institute (NCI) NA
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00019513 Completed National Institutes of Health Clinical Center (CC) NA
NCT00019019 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas https://ClinicalTrials.gov/show/NCT00019019 Completed National Institutes of Health Clinical Center (CC) 2006-07-31
NCT00006379 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA https://ClinicalTrials.gov/show/NCT00006379 Completed Case Comprehensive Cancer Center 2004-01-31
NCT00006340 Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus https://ClinicalTrials.gov/show/NCT00006340 Completed Boston Medical Center 2000-07-31
NCT00006221 BMS-247550 in Treating Patients With Advanced Cancers https://ClinicalTrials.gov/show/NCT00006221 Completed National Cancer Institute (NCI) 2005-06-30
NCT00005639 Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00005639 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-07-31
NCT00005590 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00005590 Completed National Cancer Institute (NCI) NA
NCT00005049 Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00005049 Completed NYU Langone Health 2006-11-30
NCT00004189 Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00004189 Completed National Cancer Institute (NCI) 2003-07-31
NCT00004066 Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00004066 Completed Memorial Sloan Kettering Cancer Center 2003-10-31
NCT00003993 Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00003993 Completed National Cancer Institute (NCI) 2008-07-31
NCT00003687 Treatment for Chronic Pain in Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00003687 Completed Canadian Cancer Trials Group 2001-09-26

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03328065 Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum or Lung, or Gastrointestinal Neuroendocrine Tumours https://ClinicalTrials.gov/show/NCT03328065 Recruiting Centre Hospitalier Universitaire Dijon 2020-12-31
NCT03017690 Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) https://ClinicalTrials.gov/show/NCT03017690 Completed Ipsen 2018-05-30
NCT02853422 Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours https://ClinicalTrials.gov/show/NCT02853422 Completed Ipsen 2017-01-31
NCT02788565 Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours https://ClinicalTrials.gov/show/NCT02788565 Completed Ipsen 2016-10-31
NCT02730104 Community-based Neuroendocrine Tumor (NET) Research Study https://ClinicalTrials.gov/show/NCT02730104 Completed Ipsen 2020-05-13
NCT02005965 Low Rectal Cancer Study (MERCURY II) https://ClinicalTrials.gov/show/NCT02005965 Active, not recruiting Royal Marsden NHS Foundation Trust 2016-03-11
NCT01995942 Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial https://ClinicalTrials.gov/show/NCT01995942 Active, not recruiting Royal Marsden NHS Foundation Trust 2017-02-02
NCT01750619 Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions https://ClinicalTrials.gov/show/NCT01750619 Recruiting California Pacific Medical Center Research Institute 2021-12-31
NCT03958188 PreOPerative Imaging of NeuroEndocrine Tumors https://ClinicalTrials.gov/show/NCT03958188 Active, not recruiting Hospices Civils de Lyon 2019-06-30
NCT03817866 Chromogranin A as Blood Marker in Cancer Patients https://ClinicalTrials.gov/show/NCT03817866 Recruiting Brahms AG 2021-12-31
NCT03771508 Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA) https://ClinicalTrials.gov/show/NCT03771508 Recruiting Medtronic - MITG 2021-01-31
NCT03659357 Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE) https://ClinicalTrials.gov/show/NCT03659357 Enrolling by invitation Tongji Hospital 2020-09-30
NCT00956475 Quality of Life in Younger Leukemia and Lymphoma Survivors https://ClinicalTrials.gov/show/NCT00956475 Completed Case Comprehensive Cancer Center 2010-09-30
NCT00897923 Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00897923 Completed Mayo Clinic 2012-02-10
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT00489515 Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder https://ClinicalTrials.gov/show/NCT00489515 Completed Wake Forest University Health Sciences 2009-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31